Search
Azelastine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175128Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDimenhydrinate H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175133Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typePheniramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175091Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeCetirizine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175121Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDoxylamine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0058803Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeLoratadine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175122Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeDesloratadine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175124Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeLevocetirizine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175093Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeQuetiapine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175112Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha typeChlorpheniramine H1-Antihistamine Immune Response Action Pathway
smpdb.ca/view/SMP0175134Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Protein kinase C alpha type